Portfolio company
Itay&Beyond
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops patient-derived brain organoids and an artificial intelligence platform for pharmaceutical firms to test drug efficacy for neurological and psychiatric disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BrainZell
The company develops brain organoid models and computational tools for pharmaceutical firms to discover central nervous system drugs and test their efficacy.
Bexorg
Bexorg provides an AI-powered perfusion platform using post-mortem human brains to facilitate central nervous system drug discovery for pharmaceutical and academic researchers.
NeuraLight
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
MeOmics
The company develops a precision psychiatry platform using patient-derived stem cells and AI to help drug developers accelerate psychiatric medicine discovery.
RebrAIn
The company develops artificial intelligence software to help neurosurgeons identify optimal brain targets for deep brain stimulation and lesioning treatments.
Archean Sciences
Archean Sciences develops brain-on-a-chip systems using living human neurons to provide drug testing and energy-efficient computing for pharmaceutical and artificial intelligence firms.
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
